Literature DB >> 18522893

Isolated hepatosplenic tuberculosis.

Vinay Kumar1, Durgatosh Pandey.   

Abstract

BACKGROUND: Tuberculosis rarely involves the liver and spleen and when it does so, it is usually associated with disseminated disease.
METHOD: We report a patient with isolated tuberculosis of the liver and spleen.
RESULTS: A 50-year-old man presented with weakness and loss of weight for two months. CT scan of the abdomen showed multiple small hypodense lesions in the liver and spleen. Image-guided biopsy of liver lesion was inconclusive as it showed normal hepatocytes with interspersed lymphocytes. On laparotomy, the liver and spleen were studded with multiple small nodules. A 5-cm wedge of the liver was resected. Histopathological examination confirmed the diagnosis of tubercular hepatitis. A detailed work-up failed to identify any other focus of tuberculosis.
CONCLUSION: Although rare, tuberculosis should also be considered in the differential diagnosis for multiple nodules in the liver and spleen, along with lymphoproliferative diseases and metastatic lesions.

Entities:  

Mesh:

Year:  2008        PMID: 18522893

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  4 in total

1.  Isolated hepatosplenic tuberculosis: a rare presentation.

Authors:  Roumina Hasan; Sandeep Kumar; Mary Mathew; Rajagopal Kadavigere
Journal:  BMJ Case Rep       Date:  2015-07-07

2.  Hepatosplenic tuberculosis simulating secondary malignant lesions with cholangitis.

Authors:  Ibrahima Diallo; Ababacar Mbengue; Sara B Gning; Mouhamed A Amar; Bineta Ndiaye; Yankhoba Diop; Fatou Fall; Papa S MBaye
Journal:  BMC Res Notes       Date:  2016-06-20

3.  Isolated primary tuberculosis of spleen-A rare entity in the immuno-competent patient.

Authors:  Suneed Kumar; Ajay G Pai; Pravin N Tungenwar; Ajay H Bhandarwar
Journal:  Int J Surg Case Rep       Date:  2016-11-25

4.  The liver Metastatic Adenocarcinoma of Colorectal Cancer With Synchronous Isolated Hepatic Tuberculosis.

Authors:  Mohammadreza Hafezi Ahmadi; Hadi Teimouri; Sajjad Alizadeh
Journal:  Hepat Mon       Date:  2013-05-16       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.